Literature DB >> 12220963

Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats.

Hanan H Hagar1.   

Abstract

Hyperhomocysteinemia (Hhcy) is an independent risk factor for cardiovascular disease. Oxidative stress may contribute to the deleterious effects of homocysteine (Hcy). The aim of the present study is to study the effect of folic acid and Vitamin B(12) supplementation on isoprenaline (ISO)-induced myocardial infarction (MI) in hyperhomocysteinemic rats. Hhcy was induced by daily intake of methionine (1 g kg(-1) body weight) in the drinking water for 4 weeks. MI was then produced by a single subcutaneous injection of ISO (300 mg kg(-1), s.c.). Electrocardiographic parameters, heart rate, ST segment, and blood pressure as well as serum marker enzymes, creatine kinase (CK) and lactate dehydrogenase (LDH) were measured. Lipid peroxidation measured as malondialdehyde (MDA) and reduced glutathione (GSH) concentrations in heart tissue were estimated as indices of oxidative stress. Hhcy resulted in significant blood pressure reduction, ST segment elevation and increase in heart rate and serum CK and LDH levels. Cardiac MDA was significantly increased, while GSH was decreased in Hhcy group compared to the normal control group. All the measured parameters were greatly exaggerated in Hhcy rats treated with ISO in comparison with Hhcy rats alone. Administration of folic acid (10 mg kg(-1), orally via gavage) and Vitamin B(12) (500 microg kg(-1), i.m.) concurrently for 4 weeks during the induction of Hhcy markedly reduced the increase in heart rate, ST segment elevation and blood pressure reduction as well as the increase in serum CK and LDH levels. Cardiac MDA content was decreased while cardiac GSH was elevated in the treated group compared to Hhcy + ISO group. Moreover, the severe cardiac histopathological changes observed in Hhcy + ISO group were attenuated by folic acid and Vitamin B(12). These results suggest that Hhcy aggravates MI via oxidative stress mechanisms and that lowering Hcy level with folic acid and Vitamin B(12) can ameliorate the detrimental effects of Hhcy and may reduce the risk of MI. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220963     DOI: 10.1016/s1043-6618(02)00095-6

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  16 in total

1.  Putative antioxidant property of sesame oil in an oxidative stress model of myocardial injury.

Authors:  Mohamed T S Saleem; Madhusudhana C Chetty; S Kavimani
Journal:  J Cardiovasc Dis Res       Date:  2013-11-01

2.  Role of Oxytocin in deceleration of early atherosclerotic inflammatory processes in adult male rats.

Authors:  Marwa A Ahmed; Gehan M Elosaily
Journal:  Int J Clin Exp Med       Date:  2011-09-15

3.  Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats.

Authors:  B Ganesan; S Buddhan; R Anandan; R Sivakumar; R AnbinEzhilan
Journal:  Mol Biol Rep       Date:  2009-03-15       Impact factor: 2.316

4.  Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats.

Authors:  Bhoomika R Goyal; Pravin Mesariya; Ramesh K Goyal; Anita A Mehta
Journal:  Mol Cell Biochem       Date:  2008-04-19       Impact factor: 3.396

5.  Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.

Authors:  Ya-fei Shi; Ju-fang Chi; Wei-liang Tang; Fu-kang Xu; Long-bin Liu; Zheng Ji; Hai-tao Lv; Hang-yuan Guo
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

6.  Antihyperhomocysteinemic and antihyperlipidemic effect of Trichilia connaroides in methionine-induced hyperhomocysteinemic animals.

Authors:  G S Prasanna; Purnima Ashok
Journal:  Indian J Pharmacol       Date:  2011-04       Impact factor: 1.200

7.  Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats.

Authors:  Snehal S Patel; Ramesh K Goyal
Journal:  Pharmacognosy Res       Date:  2011-10

8.  Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy.

Authors:  Guoguang Wang; Wei Li; Xiaohua Lu; Xue Zhao
Journal:  Heart Int       Date:  2011-11-22

9.  Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats.

Authors:  Yogeeta O Agrawal; Pankaj Kumar Sharma; Birendra Shrivastava; Shreesh Ojha; Harshita M Upadhya; Dharamvir Singh Arya; Sameer N Goyal
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

10.  Further studies on antioxidant potential and protection of pancreatic beta-cells by Embelia ribes in experimental diabetes.

Authors:  Uma Bhandari; Neeti Jain; K K Pillai
Journal:  Exp Diabetes Res       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.